Literature DB >> 2538060

In situ demonstration of Epstein-Barr viral genomes in viral-associated B cell lymphoproliferations.

L M Weiss1, L A Movahed.   

Abstract

Thirteen cases of benign and malignant Epstein-Barr viral (EBV)-associated B cell lymphoproliferations were examined by in situ hybridization studies performed on formalin-fixed, paraffin-embedded tissue sections. EBV nucleic acids were identified in a minority of lymphoid cells in five of six cases of benign infectious mononucleosis studied in tonsil or lymph node specimens. No evidence of EBV was found in two splenectomy specimens from patients with infectious mononucleosis. EBV nucleic acids were identified in one case of fatal, infectious, mononucleosislike immunoblastic proliferation, and were especially concentrated in areas where there were sheets of immunoblasts associated with necrosis. EBV nucleic acids were identified in all four cases of EBV-associated post-transplant lymphoproliferations, including three cases of non-Hodgkin's lymphoma in which a majority of the neoplastic cells contained EBV nucleic acids.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2538060      PMCID: PMC1879531     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  24 in total

Review 1.  Epstein-Barr virus, immunodeficiency, and B cell lymphoproliferation.

Authors:  D W Hanto; G Frizzera; K J Gajl-Peczalska; R L Simmons
Journal:  Transplantation       Date:  1985-05       Impact factor: 4.939

2.  Persistence of Epstein-Barr virus in the parotid gland.

Authors:  H Wolf; M Haus; E Wilmes
Journal:  J Virol       Date:  1984-09       Impact factor: 5.103

3.  Demonstration of Epstein-Barr virus (EBV) DNA in oral hairy leukoplakia using in situ hybridization with biotinylated probe.

Authors:  S Syrjänen; P Laine; S L Valle
Journal:  Proc Finn Dent Soc       Date:  1988

4.  Long internal direct repeat in Epstein-Barr virus DNA.

Authors:  A Cheung; E Kieff
Journal:  J Virol       Date:  1982-10       Impact factor: 5.103

Review 5.  Epstein-Barr virus and the X-linked lymphoproliferative syndrome.

Authors:  J L Sullivan
Journal:  Adv Pediatr       Date:  1983

6.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity.

Authors:  A P Feinberg; B Vogelstein
Journal:  Anal Biochem       Date:  1983-07-01       Impact factor: 3.365

7.  Epstein-Barr virus replication in oropharyngeal epithelial cells.

Authors:  J W Sixbey; J G Nedrud; N Raab-Traub; R A Hanes; J S Pagano
Journal:  N Engl J Med       Date:  1984-05-10       Impact factor: 91.245

8.  Use of cloned probes to detect Epstein-Barr viral DNA in tissues of patients with neoplastic and lymphoproliferative diseases.

Authors:  W Andiman; L Gradoville; L Heston; R Neydorff; M E Savage; G Kitchingman; D Shedd; G Miller
Journal:  J Infect Dis       Date:  1983-12       Impact factor: 5.226

9.  Replication of Epstein-Barr virus in human epithelial cells infected in vitro.

Authors:  J W Sixbey; E H Vesterinen; J G Nedrud; N Raab-Traub; L A Walton; J S Pagano
Journal:  Nature       Date:  1983 Dec 1-7       Impact factor: 49.962

10.  The Epstein-Barr virus in the pathogenesis of posttransplant lymphoproliferative disorders. Clinical, pathologic, and virologic correlation.

Authors:  D W Hanto; K Sakamoto; D T Purtilo; R L Simmons; J S Najarian
Journal:  Surgery       Date:  1981-08       Impact factor: 3.982

View more
  29 in total

1.  Multivisceral intestinal transplantation: surgical pathology.

Authors:  R Jaffe; J D Trager; A Zeevi; E Sonmez-Alpan; R Duquesnoy; S Todo; M Rowe; T E Starzl
Journal:  Pediatr Pathol       Date:  1989

2.  High levels of Epstein-Barr virus DNA in blood of solid-organ transplant recipients and their value in predicting posttransplant lymphoproliferative disorders.

Authors:  F Baldanti; P Grossi; M Furione; L Simoncini; A Sarasini; P Comoli; R Maccario; R Fiocchi; G Gerna
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

3.  Detection of Epstein-Barr virus genome in Ki-1 (CD30)-positive, large-cell anaplastic lymphomas using the polymerase chain reaction.

Authors:  C W Ross; J A Schlegelmilch; T M Grogan; L M Weiss; B Schnitzer; C A Hanson
Journal:  Am J Pathol       Date:  1992-08       Impact factor: 4.307

Review 4.  In situ hybridisation in perspective.

Authors:  A Warford; I Lauder
Journal:  J Clin Pathol       Date:  1991-03       Impact factor: 3.411

Review 5.  Lymphoproliferative disease in organ transplant recipients.

Authors:  M A Nalesnik
Journal:  Springer Semin Immunopathol       Date:  1991

6.  Detection of single copies of Epstein-Barr virus in paraffin wax sections by non-radioactive in situ hybridisation.

Authors:  P J Coates; W P Mak; G Slavin; A J d'Ardenne
Journal:  J Clin Pathol       Date:  1991-06       Impact factor: 3.411

7.  Abundant expression of EBER1 small nuclear RNA in nasopharyngeal carcinoma. A morphologically distinctive target for detection of Epstein-Barr virus in formalin-fixed paraffin-embedded carcinoma specimens.

Authors:  T C Wu; R B Mann; J I Epstein; E MacMahon; W A Lee; P Charache; S D Hayward; R J Kurman; G S Hayward; R F Ambinder
Journal:  Am J Pathol       Date:  1991-06       Impact factor: 4.307

Review 8.  Role of donor versus recipient type Epstein-Barr virus in post-transplant lymphoproliferative disorders.

Authors:  T Haque; D H Crawford
Journal:  Springer Semin Immunopathol       Date:  1998

9.  In situ polymerase chain reaction-based localization studies support role of human herpesvirus-8 as the cause of two AIDS-related neoplasms: Kaposi's sarcoma and body cavity lymphoma.

Authors:  K E Foreman; P E Bacon; E D Hsi; B J Nickoloff
Journal:  J Clin Invest       Date:  1997-06-15       Impact factor: 14.808

10.  The systemic distribution of Epstein-Barr virus genomes in fatal post-transplantation lymphoproliferative disorders. An in situ hybridization study.

Authors:  P S Randhawa; R Jaffe; A J Demetris; M Nalesnik; T E Starzl; Y Y Chen; L M Weiss
Journal:  Am J Pathol       Date:  1991-04       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.